Tecogen Stock Price, News & Analysis

Tecogen (NYSE American:TGEN) has scheduled its Q2 2025 earnings release for Tuesday, August 12th, 2025 after market close. The company will host a conference call and webcast to discuss the quarterly results on Wednesday, August 13th at 9:30 AM ET.

The earnings release and supplemental presentation will be available on Tecogen's website in the Investor Relations section. Investors can access the conference call by dialing 877-407-7186 (US/Canada) or 201-689-8052 (International). A playback will be available using Access ID #13752231, and the webcast will be archived for 14 days.

Tecogen (NYSE American:TGEN), a clean energy products manufacturer, has appointed Roger Deschenes as its new Chief Financial Officer and Treasurer. Deschenes, who previously served as the company's Chief Accounting Officer, brings extensive public company experience from his prior roles as Division CFO at L3 Security, CFO at Implant Sciences Corporation, and CAO at Saucony.

CEO Abinand Rangesh highlighted Deschenes' 5-year tenure with Tecogen's finance team and expressed confidence that this appointment will strengthen the company's financial systems and support its growth initiatives.

Tecogen (NYSE American:TGEN) has successfully closed its underwritten public offering of 3,985,000 shares of common stock at $5.00 per share, including the full exercise of the underwriter's option for an additional 485,000 shares. The offering generated gross proceeds of approximately $19.9 million.

The company plans to utilize the net proceeds for product development, expanding sales and marketing efforts, hiring additional personnel, and capital expenditures, with a particular focus on expansion into the data center market. Roth Capital Partners LLC served as the sole manager and underwriter for the offering.

Tecogen (NYSE American:TGEN) has announced the pricing of its underwritten public offering of 3.5 million shares of common stock at $5 per share, expecting to raise gross proceeds of approximately $17.5 million. The offering is set to close around July 21, 2025, with underwriters having a 45-day option to purchase up to 485,000 additional shares.

Roth Capital Partners is serving as the sole manager for this offering. The company plans to use the proceeds for product development, sales and marketing expansion, human resources, capital expenditures, and its planned expansion into the data center market, along with general working capital purposes.

Tecogen Inc. (NYSE American: TGEN), a clean energy products manufacturer, announced its participation in the upcoming 15th Annual Roth Conference in London from June 24-26, 2025. CEO Abinand Rangesh will be available for one-on-one meetings with investors during the event. Interested investors can schedule meetings through their Roth representative or by contacting Tecogen's investor relations via email.

Tecogen (NYSE American: TGEN) announced that CEO Abinand Rangesh will participate in Semco Capital's 6th Annual CEO Event in Chicago on June 2, 2025. The event, scheduled from 1-9 p.m. CT, will feature Dr. Rangesh in a fireside chat hosted by Scott Weis of Semco Capital. The event focuses on showcasing microcap companies with strong management teams and growth potential. Interested investors can contact Scott Weis for attendance information.

Tecogen (NYSE American: TGEN) reported its Q1 2025 financial results, showing improved performance across key metrics. The company achieved revenues of $7.28 million, up 17.6% from $6.19 million in Q1 2024. The net loss decreased to $0.66 million ($0.03/share) from $1.10 million ($0.04/share) in the previous year. Gross margin improved to 44.3% from 41.6%. Products revenue saw significant growth of 69.9% to $2.53 million, while Services revenue increased 5.7% to $4.25 million. Energy Production revenue declined 26.7% to $0.50 million. The company's adjusted EBITDA loss narrowed to $0.38 million from $0.90 million. Operating expenses increased 5.2% to $3.82 million due to increased payroll, benefits, and recruitment costs. The company recently uplisted to NYSE American to enhance stock liquidity and visibility.

Tecogen Inc. (NYSE American:TGEN) has announced it will release its Q1 2025 financial results on Monday, May 12th, 2025 after market close. The company will host a conference call and webcast to discuss the quarterly results on May 13th at 9:30 AM Eastern Time.

Investors can access the conference call by dialing 877-407-7186 (US/Canada) or 201-689-8052 (International). A webcast replay will be available for 7 days following the call, and a telephone playback can be accessed using Access ID #13752231.

Tecogen has achieved a significant milestone with its approval to uplist from the OTCQX Best Market to the NYSE American stock exchange. The clean energy products manufacturer will maintain its current trading symbol "TGEN" when it begins trading on the NYSE American on May 6th, 2025.

The company will continue trading on the OTCQX until market close on May 5th, 2025. Current stockholders are not required to take any action regarding this transition. CEO Abinand Rangesh highlighted that this uplisting is expected to provide three key benefits:

• Enhanced visibility in the market
• Expanded investor base
• Improved share liquidity for current and future stockholders